Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Skin cells control immune cell placement, helping the skin respond better to challenges.

IL-17 and certain immune cells are linked to more severe alopecia areata.

IL-26 has antimicrobial and pro-inflammatory effects in the chronic skin condition Hidradenitis Suppurativa.

Immune-epithelial interactions are crucial for tissue repair, but unchecked can cause diseases.

Thymus-derived Tregs, not peripherally-derived Tregs, primarily regulate type 1 diabetes in the NOD mouse model.

Dual TCR Treg cells are common in mouse tissues and vary by location.

Targeting THY1 can improve skin repair and healing.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

B cells can both help and hinder the body's defense against melanoma.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

Enhancing Tregs can protect against alopecia areata.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

A specific group of slow-growing stem cells marked by Thy1 is crucial for skin maintenance and healing in mice.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.